Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy LeMaitre Vascular stock
Learn how to easily invest in LeMaitre Vascular stock.
LeMaitre Vascular Inc is a medical instruments & supplies business based in the US. LeMaitre Vascular shares (LMAT) are listed on the NASDAQ and all prices are listed in US Dollars. LeMaitre Vascular employs 386 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in LeMaitre Vascular
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LMAT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
LeMaitre Vascular stock price (NASDAQ: LMAT)Use our graph to track the performance of LMAT stocks over time.
LeMaitre Vascular shares at a glance
|Latest market close||$42.83|
|52-week range||$41.68 - $64.23|
|50-day moving average||$49.02|
|200-day moving average||$53.31|
|Wall St. target price||$65.86|
|Dividend yield||$0.425 (1%)|
|Earnings per share (TTM)||$1.33|
Buy LeMaitre Vascular shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy LeMaitre Vascular stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
LeMaitre Vascular price performance over time
|1 week (2022-01-15)||N/A|
|1 month (2021-12-23)||-16.90%|
|3 months (2021-10-26)||-22.35%|
|6 months (2021-07-26)||-21.50%|
|1 year (2021-01-26)||-10.02%|
|2 years (2020-01-24)||17.41%|
|3 years (2019-01-25)||82.49%|
|5 years (2017-01-26)||85.09%|
Is LeMaitre Vascular stock undervalued or overvalued?
Valuing LeMaitre Vascular stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LeMaitre Vascular's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
LeMaitre Vascular's P/E ratio
LeMaitre Vascular's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, LeMaitre Vascular shares trade at around 33x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
LeMaitre Vascular's PEG ratio
LeMaitre Vascular's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.005. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LeMaitre Vascular's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
LeMaitre Vascular's EBITDA
LeMaitre Vascular's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $48.4 million.
The EBITDA is a measure of a LeMaitre Vascular's overall financial performance and is widely used to measure a its profitability.
LeMaitre Vascular financials
|Revenue TTM||$152.5 million|
|Operating margin TTM||24.71%|
|Gross profit TTM||$84.6 million|
|Return on assets TTM||8.55%|
|Return on equity TTM||13.54%|
|Market capitalisation||$964.8 million|
TTM: trailing 12 months
LeMaitre Vascular share dividends
Dividend payout ratio: 33.33% of net profits
Recently LeMaitre Vascular has paid out, on average, around 33.33% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), LeMaitre Vascular shareholders could enjoy a 1% return on their shares, in the form of dividend payments. In LeMaitre Vascular's case, that would currently equate to about $0.425 per share.
While LeMaitre Vascular's payout ratio might seem fairly standard, it's worth remembering that LeMaitre Vascular may be investing much of the rest of its net profits in future growth.
LeMaitre Vascular's most recent dividend payout was on 1 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 17 November 2021 (the "ex-dividend date").
LeMaitre Vascular share price volatility
Over the last 12 months, LeMaitre Vascular's shares have ranged in value from as little as $41.68 up to $64.2341. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LeMaitre Vascular's is 1.3147. This would suggest that LeMaitre Vascular's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
LeMaitre Vascular overview
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular patches, which are used for closure of vessels after surgical intervention; closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. It markets its products through a direct sales force and distributors.
LeMaitre Vascular in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Frequently asked questionsWhat percentage of LeMaitre Vascular is owned by insiders or institutions?
Currently 12.17% of LeMaitre Vascular shares are held by insiders and 87.854% by institutions. How many people work for LeMaitre Vascular?
Latest data suggests 386 work at LeMaitre Vascular. When does the fiscal year end for LeMaitre Vascular?
LeMaitre Vascular's fiscal year ends in December. Where is LeMaitre Vascular based?
LeMaitre Vascular's address is: 63 Second Avenue, Burlington, MA, United States, 01803 What is LeMaitre Vascular's ISIN number?
LeMaitre Vascular's international securities identification number is: US5255582018 What is LeMaitre Vascular's CUSIP number?
LeMaitre Vascular's Committee on Uniform Securities Identification Procedures number is: 525558201
More guides on Finder
How to buy Core Scientific stock
Steps to owning and managing CORZ, with 24-hour and historical pricing before you buy.
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Ask an Expert